Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print December 26, 2007, DOI:10.2164/jandrol.107.004713

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
29/3/e1    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Brannigan, R. E.
Right arrow Articles by Sandlow, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brannigan, R. E.
Right arrow Articles by Sandlow, J.

Androlog Summary: Cryopreservation of Sperm After Chemotherapy

Robert E. Brannigan * and Jay Sandlow

* To whom correspondence should be addressed. E-mail: r-brannigan{at}northwestern.edu.

Fertility preservation in male cancer patients is a topic that has garnered much attention in recent years. Improved diagnostic and therapeutic modalities have enabled increasing numbers of men with cancer to look past their oncologic diagnosis toward life after cancer. Unfortunately, cancer and cancer treatments often render afflicted patients infertile. Despite the initiatives calling for early attention to fertility preservation procedures, urologists are still faced with clinical scenarios where patients are sent for sperm cryopreservation after having received gonadotoxic chemotherapy or radiation therapy. The below string of Androlog entries highlights approaches to this challenging clinical problem.


Key words: Infertility • Sperm • Cancer • Chemotherapy • Fertility preservation






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by The American Society of Andrology.